Wei-Lun Tang

Title: Wei-Lun Tang: Innovator in Cancer Therapeutics

Introduction

Wei-Lun Tang is an accomplished inventor based in Toronto, Canada, known for his significant contributions to the field of drug delivery systems. With a focus on enhancing cancer treatment, he has developed innovative technologies that aim to improve the efficacy and safety of therapeutic agents.

Latest Patents

Wei-Lun Tang holds a patent for "Cellulose-based nanoparticles for drug delivery." This patent includes a compound consisting of acetylated carboxymethylcellulose (CMC-Ac) that is covalently linked to at least one poly(ethylene glycol) (PEG) and at least one hydrophobic drug. Furthermore, it describes a self-assembling nanoparticle composition comprised of such compounds, which offers promising applications in targeted cancer therapy.

Career Highlights

Currently, Wei-Lun Tang is affiliated with the Ontario Institute for Cancer Research, where he engages in pioneering research aimed at combating cancer. His efforts in the field have positioned him as a key contributor to advancements in drug delivery mechanisms.

Collaborations

Throughout his career, Wei-Lun Tang has collaborated with esteemed colleagues, including Shyh-Dar Li and Mark John Ernsting. These partnerships foster innovative research and development, enhancing the capabilities and applications of his inventions in the medical field.

Conclusion

Wei-Lun Tang's work in the development of cellulose-based nanoparticles marks a significant advancement in drug delivery systems for cancer treatment. With his ongoing contributions and collaborations at the Ontario Institute for Cancer Research, he continues to play a vital role in the innovation and application of new therapeutic strategies that hold the potential to improve patient outcomes in oncology.